Masters Specialty Pharma Announces Launch of Neuropad® for the Detection of Diabetic Foot Syndrome
![Masters Specialty Pharma Announces Launch of Neuropad® for the Detection of Diabetic Foot Syndrome](http://cdn-61f27c22c1ac18f874f851d3.closte.com/wp-content/uploads/2023/03/neuropad.jpg)
Masters Speciality Pharma (“Masters”), a UK-headquartered pharmaceutical company specialising in the global distribution of high-quality, life-changing medicines, today announces the recent launch in Brazil of Neuropad®, a rapid and reliable screening test for diabetic foot syndrome. …[read more]